Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
28 hedge funds and large institutions have $12.3M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
11% more capital invested
Capital invested by funds: $11.1M → $12.3M (+$1.22M)
4% more funds holding
Funds holding: 27 → 28 (+1)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$306K |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$64.4K |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$63.5K |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$27.9K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$658 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$306K |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$154K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$124K |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$95K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$73.4K |
VHAQ.WS Hedge Fund Activity: Q2 2021 in Review
28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q2 2021, worth a combined $12.3M — up 11% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VHAQ.WS positions and 5 closed out — a net gain of 1 holder — while 1 added to existing stakes and 8 trimmed.
The largest buyer was Linden Advisors, adding an estimated $306K. The largest seller was K2 Principal Fund, exiting entirely with an estimated $306K sold.
- 28 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q2 2021, up from 27 in Q1 2021.
- Funds reported $12.3M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q2 2021, up 11% quarter-over-quarter.
- 6 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q2 2021 and 5 closed out, a net change of +1 holder.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q2 2021 was Linden Advisors, an estimated $306K added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q2 2021 was K2 Principal Fund, an estimated $306K sold.
Based on aggregated 13F filings for Q2 2021.